{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:27:03Z","timestamp":1794230823635,"version":"4.9.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcyt.2025.102038","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:15:41Z","timestamp":1766621741000},"page":"102038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Establishing practical predictors of collection efficiency for optimized chimeric antigen receptor T-cell apheresis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0088-0488","authenticated-orcid":false,"given":"Han Joo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongsuk","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Bum","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2025.102038_bib0001","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcyt.2022.05.003","article-title":"Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing","volume":"24","author":"Qayed","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2025.102038_bib0002","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jcyt.2022.02.007","article-title":"Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis","volume":"24","author":"Liu","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2025.102038_bib0003","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcyt.2022.05.002","article-title":"Recommendations for procurement of starting materials by apheresis for advanced therapy medicinal products","volume":"24","author":"Manson","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2025.102038_bib0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jca.21964","article-title":"Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: comprehensive review of over 600 studies","volume":"37","author":"Thibodeaux","year":"2022","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2025.102038_bib0005","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/trf.18216","article-title":"Apheresis collection parameters for approved CAR T-cell products need to be standardized","volume":"65","author":"Mamo","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2025.102038_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jca.21347","article-title":"Calculations in apheresis","volume":"30","author":"Neyrinck","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2025.102038_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tmrv.2016.03.001","article-title":"CAR-T cell therapies from the transfusion medicine perspective","volume":"30","author":"Fesnak","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jcyt.2025.102038_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.transci.2004.09.006","article-title":"Apheresis techniques for collection of peripheral blood progenitor cells","volume":"31","author":"Moog","year":"2004","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcyt.2025.102038_bib0009","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/S2352-3026(24)00098-X","article-title":"Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT","volume":"11","author":"Pagliuca","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jcyt.2025.102038_bib0010","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/trf.15178","article-title":"Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies","volume":"59","author":"Tuazon","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2025.102038_bib0011","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/trf.14003","article-title":"Autologous lymphapheresis for the production of chimeric antigen receptor T cells","volume":"57","author":"Allen","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2025.102038_bib0012","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/trf.17030","article-title":"Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients","volume":"62","author":"Harrer","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2025.102038_bib0013","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12185-021-03191-x","article-title":"Optimization of lymphapheresis for manufacturing autologous CAR-T cells","volume":"114","author":"Yamanaka","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jcyt.2025.102038_bib0014","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.jtct.2022.04.013","article-title":"A clinically applicable prediction model to improve T cell collection in chimeric antigen receptor T cell therapy","volume":"28","author":"Jo","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2025.102038_bib0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jcyt.2024.04.001","article-title":"Handling the different requirements for commercial and investigational MNC collections by apheresis","volume":"26","author":"Bobr","year":"2024","journal-title":"Cytotherapy"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492500934X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492500934X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:19:44Z","timestamp":1780816784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492500934X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S146532492500934X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102038","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing practical predictors of collection efficiency for optimized chimeric antigen receptor T-cell apheresis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102038"}}